Okazaki Fragment Processing-independent Role for Human Dna2 Enzyme during DNA Replication by Duxin, Julien P. et al.
Okazaki Fragment Processing-independent Role for Human
Dna2 Enzyme during DNA Replication*□S
Received for publication,March 5, 2012, and in revised form, April 25, 2012 Published, JBC Papers in Press,May 7, 2012, DOI 10.1074/jbc.M112.359018
Julien P. Duxin‡§, Hayley R. Moore‡§, Julia Sidorova¶, Kenneth Karanja, Yuchi Honaker‡§, Benjamin Dao‡§,
Helen Piwnica-Worms‡§**, Judith L. Campbell, Raymond J. Monnat, Jr.¶, and Sheila A. Stewart‡§**1
From the ‡Department of Cell Biology and Physiology, §BRIGHT Institute, St. Louis, Missouri 633110, the ¶Department of Pathology,
University of Washington, Seattle, Washington 98195, Braun Laboratories, California Institute of Technology, Pasadena,
California 91125, and the **Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 633110
Background: Dna2 and FEN1 putatively cooperate in Okazaki fragment (OF) processing in yeast.
Results: FEN1 depletion leads to OF maturation defects that do not impact replication fork kinetics, whereas hDna2 depletion
leads to DNA damage independent of OF maturation.
Conclusion: hDna2 participates in DNA replication in a manner distinct from FEN1.
Significance: hDna2 participates in replication in a FEN1, OF maturation-independent manner.
Dna2 is an essential helicase/nuclease that is postulated to
cleave longDNA flaps that escape FEN1 activity duringOkazaki
fragment (OF) maturation in yeast. We previously demon-
strated that the human Dna2 orthologue (hDna2) localizes to
the nucleus and contributes to genomic stability. Here we inves-
tigated the role hDna2 plays in DNA replication. We show that
Dna2 associateswith the replisomeproteinAnd-1 in a cell cycle-
dependentmanner. Depletion of hDna2 resulted in S/G2 phase-
specific DNA damage as evidenced by increased -H2AX, repli-
cation protein A foci, and Chk1 kinase phosphorylation, a
readout for activation of theATR-mediated S phase checkpoint.
In addition, we observed reduced origin firing in hDna2-de-
pleted cells consistent with Chk1 activation.We next examined
the impact of hDna2 onOFmaturation and replication fork pro-
gression in human cells. As expected, FEN1 depletion led to a
significant reduction in OF maturation. Strikingly, the reduc-
tion in OF maturation had no impact on replication fork pro-
gression, indicating that forkmovement is not tightly coupled to
lagging strand maturation. Analysis of hDna2-depleted cells
failed to reveal a defect in OF maturation or replication fork
progression. Prior work in yeast demonstrated that ectopic
expression of FEN1 rescues Dna2 defects. In contrast, we found
that FEN1 expression in hDna2-depleted cells failed to rescue
genomic instability. These findings suggest that the genomic
instability observed in hDna2-depleted cells does not arise from
defective OF maturation and that hDna2 plays a role in DNA
replication that is distinct from FEN1 and OF maturation.
Genomic maintenance requires coordination of several pro-
cesses including DNA replication, DNA repair, transcription,
and cell cycle progression. Given the importance of genomic
stability for ongoing cell proliferation, it is not surprising that
DNA replication and repair proteins have evolved multiple
functions and participate in several replication and repair path-
ways. Previously, we demonstrated that human Dna2 (hDna2)2
localizes to the nucleus and mitochondria and participates in
DNA maintenance in both compartments (1). Dna2 is a highly
conserved helicase/nuclease, originally discovered in Saccharo-
myces cerevisiae and found in all organisms from yeast to
humans (2–6). Dna2 possesses a 5 to 3 ATP-dependent heli-
case activity and a flap endonuclease activity (7). Genetic and
biochemical experiments conducted in yeast support a model
in which Dna2 contributes to Okazaki fragment (OF) matura-
tion in lagging strand DNA replication (8–10), although in vivo
evidence of Dna2 participating in this process is lacking.
During OF processing, flap endonuclease 1 (FEN1) is the
major endonuclease that acts in a coordinated manner with
DNA polymerase  strand displacement activity to remove
short RNA/DNA flaps formed on the previous OF (short flap
pathway OF processing) (9–12). Flaps that escape FEN1 cleav-
age and are longer than 27 nucleotides are subsequently coated
by replication protein A (RPA), which inhibits FEN1 nuclease
activity (long flap pathway OF processing) (9, 12, 13). RPA-
bound OF flaps recruit Dna2, which cleaves the RPA-coated
DNA and displaces RPA, leaving a short 5–6-nucleotide RNA-
free DNA flap that is further processed by FEN1 to produce a
ligatable nick (9, 10, 14–18). In support of this long flap model,
both PIF1 helicase and polymerase  processivity subunit (Pol
32) promote long flap formation in vitro, and their deletion
rescues the lethality associated with yeast Dna2 loss, presum-
ably because long flaps no longer form (12, 19–22). Conversely,
mutations that increase polymerase  processivity are synthet-
ically lethal with dna2mutations (19).
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In addition to its role in OF processing, Dna2 functions in
DNA repair and telomere maintenance through its DNA end-
resection activity. In yeast, Dna2 undergoes a dynamic localiza-
tion where it is present at telomeres in G1, relocalizes through-
out the genome in S phase, and moves back to the telomeres in
late S/G2 phase (23). In addition, upon bleomycin treatment,
yeast Dna2 leaves the telomere and localizes to sites of double
strand breaks (DSBs) (23). Recent studies have demonstrated
that yeast Dna2 nuclease activity participates in the formation
of a 3 single strand DNA overhang essential to initiate the
homologous recombination process or to maintain telomeric
stability (24–30). Furthermore, Nimonkar et al. (31) elegantly
reconstituted DNA end resection in vitro using purified human
proteins and demonstrated that hDna2 physically interacts
with Bloom to resect 5DNA ends in a process that depends on
hDna2 nuclease but not hDna2 helicase activity. Nonetheless,
in vivo and in vitro studies in yeast and humans indicate that
Exo1 can compensate for Dna2 nuclease activity in this process
(24, 29, 31). This suggests that the essential function of Dna2 is
not its resection activity during DSB repair but rather its func-
tion in removing long flaps during DNA replication.
Our previous work revealed that hDna2 contributes to
genomic stability (1). Here, we provide evidence that hDna2
ensures genomic stability by virtue of a critical role in DNA
replication that is independent of FEN1 and OF processing.
EXPERIMENTAL PROCEDURES
Cell Culture—U-2-OS and HeLa were grown in Dulbecco’s
modified Eagle’s medium (DMEM) (Sigma) containing 10%
heat-inactivated fetal bovine serum (FBS) and 1% penicillin/
streptomycin at 37 °C in 5% CO2.
Virus Production and Infection—Viral production and infec-
tions were carried out as described previously (1, 32). Briefly,
293T cells were transfected using TransIT-LT1 (Mirus, Madi-
son, WI), and virus was collected 48 h post-transfection. Sub-
sequent infectionswere carried out overnight in the presence of
10g/ml protamine sulfate and followed 48 h post-infection by
selection of transduced cells with 2 g/ml of puromycin. The
pLKO.1 shDna2, pResQ shDna2, and pLKO.1 shSCR lentivi-
ruses were produced by co-transfection with pCMV8.2R and
pCMV-VSV-G (8:1 ratio). The sequence for the shDna2 short
hairpin was 5-CATAGCCAGTAGTATTCGATG-3, for
shDna2was 5-GCAGTATCTCCTCTAGCTAGT-3, and for
shSCR was 5-AAGGTTAAGTCGCCCTCGCTC-3 as previ-
ously reported (1). The sequences used for the FEN1 short hair-
pins were previously reported (32). The sequence used for
the LigI-specific shLigI was 5-GCTCAAGCTGAAGAA-
GGACTA-3.
The pBabe-hygro-3xFLAG-Dna2 wild-type (wt), D294A
(nuc), K671E (hel), and D294A/K671E double mutant (dm)
cDNAs were cloned from pFastBACHTc-hDna2-FLAG and
confirmed by DNA sequencing (5). Briefly, depletion rescue
experiments utilized pBabe-Hygro-3XFLAG-Dna2 (wt, nuc,
hel or dm) or pBabe-hygro-3FLAG control constructs pro-
duced in 293T cells. U-2-OS cells were transduced with differ-
ent constructs and selected in the presence of 200g/ml hygro-
mycin B (Sigma). After selection, hDna2 overexpression was
confirmed by Western blot, and cells were transduced with
pResQ shDna2, which does not target the exogenous hDna2
cDNAs followed by puromycin selection as described above.
Five days post-infection, cells were analyzed for DNA content
by flow cytometry as previously described (Fig. 2A) (1).
For FEN1 ectopic expression experiments, viral production
and infections were carried out as described previously (32).
U-2-OS cells were infected with pLKO.1 shSCR or pLKO.1
shDna2 lentiviruses for 5 h. Cells were then counted and
reseeded in the presence of media containing Adeno-FEN1 or
Adeno-GFP (33). 48 h post-infection cells were re-plated at
0.8 106 cells/10-cmplate and then analyzed 24 to 48 h later by
hypotonic propidium iodide staining and flow cytometry as
previously described (1). FEN1 ectopic expression was con-
firmed by Western blot and immunofluorescence (data not
shown).
Immunoprecipitation and Western Blot Analysis—For
co-immunoprecipitation studies, cells were washed in PBS and
lysed in TBS-Triton X-100 buffer containing 50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and pro-
tease and phosphatase inhibitors. 2 mg of protein extracts were
immunoprecipitated with 2.4 g of anti-hDna2 or IgG control
antibodies using protein A beads overnight at 4 °C. The follow-
ing morning beads were washed 3 times in 1 ml of TBS-Triton
X-100 buffer before eluting bound proteins in 2 Laemmli
buffer by boiling for 5 min at 95 °C. Anti-hDna2 antibody was
produced as previously described (5), and anti-And-1 was
kindly provided by Dr. Anindya Dutta (34).
For the cell cycle experiments, cells were enriched in G0/G1
and G1/S by serum starvation and double thymidine block,
respectively, as previously described (35). Briefly, for G0/G1
enrichment, exponentially growing cells were cultured in
DMEMmedium containing 0.6% FBS for 38 h, then harvested,
analyzed by FACS to ensure arrest, and used for immunopre-
cipitation of hDna2 followed by Western blotting for And-1.
For G1/S enrichment, exponentially growing cells were cul-
tured in medium supplemented with 3 mM thymidine for 16 h
and washed twice in pre-warmed PBS, and fresh mediumwith-
out thymidine was added for 12 h. Then, fresh medium with 3
mM thymidine was added, and cells were grown for another
16 h.Arrestwasmonitored by flow cytometry analysis, and cells
were harvested andused for co-immunoprecipitation studies as
described above.
For Western blot analysis, cells were washed in phosphate
buffered saline (PBS), lysed inMCL buffer (50 mM Tris, pH 8.0,
5mMEDTA, 0.5%Nonidet P-40, 100mMNaCl, 2mMDTT, and
freshly added protease and phosphatase inhibitors), sonicated
(6 cycles of a 30-s pulse and 30-s cooling interval), and centri-
fuged for 20 min at 4 °C. Western blot analysis was carried out
on whole cell lysates with the following antibodies: anti-hDna2
(ab96488, Abcam, Cambridge, MA); anti-FEN1 (A300–255A,
Bethyl Laboratories, Montgomery, TX); anti-DNA Ligase I
(ab615, Abcam, Cambridge, MA); anti-FLAG M2 (F3165, Sig-
ma); anti-Chk1 (G-4 #SC-8408, Santa Cruz, Santa Cruz, CA);
anti-phospho-Chk1 (Ser-317) (36) (Cell Signaling); anti--
catenin (#610154, BD Biosciences); anti--actin (NB600-533,
Novus Biological, Littleton, CO); anti-phospho-histone H3
(Ser-10) (#9701, Cell Signaling). For Western blot analysis of
-H2AX, cellswerewashedwith PBS and lysed in radioimmune
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precipitation assay buffer (150mMNaCl, 1%TritonX-100, 0.5%
sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0, and
freshly added protease and phosphatase inhibitors) then
probed with anti-phospho-histone H2A.X (Ser-139) (clone
JBW301, #05-636, Millipore, Temecula, CA). All protein con-
centrations were measured using the Bradford assay.
Immunofluorescence—U-2-OS cells were grown for 1–2 days
on coverslips, then washed in PBS, fixed in 4% paraformalde-
hyde, and permeabilized in 0.5%TritonX-100 before treatment
with blocking buffer (10% FBS, 2% goat serum, and 0.2% Tween
20) at room temperature. Antibodies were diluted in blocking
buffer and incubated with cells for 1 h at room temperature or
overnight at 4 °C. Cells were washed in PBS containing 0.02%
Tween 20 and mounted in ProLong Gold mounting medium
(Invitrogen) containing 4, 6-diamidino-2-phenylindole
(DAPI). Immunofluorescence detection was carried out with
anti-phospho-histone H2A.X (Ser-139) (clone JBW301, #05-
636, Millipore) or anti-phospho-ATM (Ser-1981) (clone
10H11.E12, #4526, Cell Signaling) as primary antibodies. Sec-
ondary antibodies were anti-mouse IgG-Alexa-Fluor 488 or
546 (Invitrogen).
For RPA immunofluorescence, cells were pre-extracted
before fixing as previously described (37). Briefly, U-2-OS cells
were grown for 1–2 days on coverslips. Cells were washed in
ice-cold cytoskeleton (CSK) buffer (10 mM HEPES/KOH, pH
7.4, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2) and then
extracted for 6min on icewith 0.5%TritonX-100 inCSKbuffer
supplemented with protease and phosphatase inhibitors. After
extraction, cells were fixed in 3.7% formaldehyde at room tem-
perature for 25 min followed by immunofluorescence staining
using anti-replication protein A antibody (RPA-70-9, #NA13,
Calbiochem).
Internuclei Chromatin Bridges and Micronuclei Counts—
hDna2-depleted (shDna2 and shDna2) and control (shSCR)
U-2-OS cells were seeded in a 12-well plate at 5 104 cells per
well 4 days post-infection. After 36–48 h, cells were fixed and
stained with DAPI, and the number of internuclei bridges
(ICBs) andmicronuclei were counted. At least 1000 nuclei were
counted per well, and 6 wells were quantified per experiment.
Two independent experiments were quantified formicronuclei
counts in Fig. 1C and ICB counts in Fig. 5D. To inhibit Chk1,
cells were treated with either 300 nM Gö 6976 (Calbiochem)
(38) or 100 nM AZD7762 (Axon Medchem BV, The Nether-
lands) (39) for 8 h before fixing and quantification of ICBs.
Inhibition of Chk1was confirmed by flow cytometry andWest-
ern blot (Fig. 5C and data not shown). Images were processed
using Photoshop 7.0 gray scale and invert function (Adobe, San
Jose, CA).
Flow Cytometric Analysis—U-2-OS cells were seeded at
0.8  106 cells/10-cm plate 4 days post-infection and resus-
pended 36–48 h later for hypotonic propidium iodide staining
(0.1% sodium citrate tribasic, 0.3%Triton X-100, 0.01% pro-
pidium iodide, 50 g/ml RNase A (Sigma)) before flow cytom-
etry to determine DNA content as previously described (40).
SPhase ProgressionAssay—U-2-OS cellswere cultured for 30
min in the presence of 20 M bromo-2-deoxyuridine (BrdU) in
the dark as previously described (33). Briefly, cells werewashed,
cultured in fresh medium, and harvested by trypsinization at
the indicated times. Cells were washed in PBS and fixed in 4%
paraformaldehyde and 0.1% Triton X-100 in PBS for 20 min at
room temperature before DNase I treatment (30 g DNase I
(Sigma) at 37 °C for 1 h). BrdUwas detectedwith anAlexa Fluor
488-conjugated anti-BrdU antibody (A21303, Invitrogen), and
cellular DNA content was determined by propidium iodide
staining followed by flow cytometric analysis.
Metaphase Preparation andChromosome FISH—Subconflu-
ent U-2-OS cells were incubated for 3.5–4 h with 0.1 g/ml
colcemid to isolate mitotic cells by mitotic shake-off. After
hypotonic swelling in 75mMKCl for 10 min at 37 °C, cells were
fixed in methanol/acetic acid (3:1), dropped onto glass slides,
and aged at room temperature for 3 days. FISH was performed
as previously described (32). Briefly, slides were rehydrated for
10 min in PBS, fixed with 4% paraformaldehyde in PBS for 2
min, then hybridized with 0.3 g/ml telomeric PNA probe
(Cy3-(CCCTAA)3) and a centromeric probe (Flu-OO-CTT-
CGTTGGAAACGGGA) in 70% formamide, 10 mM Tris HCl,
pH 7.2, plus blocking reagent (Roche Applied Science). DNA
was denatured for 3 min at 80 °C, and hybridizations were
carried out at 37 °C for 4 h in a moist chamber. Slides were
subsequently washed, dehydrated, and mounted using
VectaShield (Vector Labs, Burlingame, CA) containing
DAPI. Images were taken using a Nikon 90i microscope and
analyzed using the ISIS FISH imaging software (Metasys-
tems, Altlussheim, Germany).
BrdU-comet Assay—The BrdU-comet assay was performed
as previously described (41). Briefly, U-2-OS cells were plated at
5 105 cells/6-cm plate and grown for 36 h at 37 °C. Cells were
then pulsed for 30 min with 100 M BrdU (Sigma) and chased
for 1–8 h in growth medium lacking BrdU. Cells were then
trypsinized and embedded in lowmelting point agarose at 37 °C
before spreading onto comet slides (Trevigen, Gaithersburg,
MD). Cells on slides were then lysed, denatured, and run
through electrophoresis under denaturing conditions (200 mM
NaOH, 1 mM EDTA) before immunostaining with anti-BrdU
antibody (#555627, BD Biosciences) for 1 h in the dark. The
primary antibody was detected using anti-mouse IgG-Alexa-
Fluor 488 (Invitrogen), and cells were counterstained with
DAPI. At least 40 comet tails were quantified per sample time
point usingCometScoreTM (TriTek). A total of three independ-
ent experiments were conducted.
Microfluidic-assisted Replication Track Analysis (maRTA)
Assay—Replication fork progression rates were determined
using maRTA (42). Briefly, hDna2-depleted (shDna2) or con-
trol (shSCR) U-2-OS cells were labeled for 30 min each with 50
M IdU followed by 50 M CldU (Sigma). For FEN1-depleted
cells, U-2OS-hTert cells were used to avoid potential telomeric
defects induced by FEN1 depletion (43). Cells were then col-
lected by trypsinization and used to prepare agarose plugs as
previously described (42). Highmolecular weightDNAwas iso-
lated fromcells embedded in agarose by brief heating to 75 °C to
melt the agarose followed by agarose digestion. The resulting
high molecular weight DNA was then loaded by capillary ten-
sion into microchannels to uniformly stretch and capture long,
high molecular weight DNA molecules on glass coverslips for
immunostaining and fluorescence microscopy. Origin firing
efficiency was determined by counting the fraction of origin
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firing events among all active replication events. Replication
elongation efficiency was determined by measuring the mean
length of first-label replication tracks in double-labeled tracks
to analyze active/ongoing fork rates. Track lengths were meas-
ured in digital images of track using the AxioVision software
package (Carl Zeiss). Three replicate samples of hDna2-de-
pleted U-2-OS cells or mock-depleted U-2-OS cells (hDna2
experiment) or FEN1 depleted U-2 OS-hTert versusmock-de-
pleted U-2 OS-hTert cells (FEN1 experiment) were analyzed
for each determination. A total of 250–450 replication tracks
were measured in each sample.
RESULTS
hDna2 Contributes to Genomic Stability—We previously
reported that hDna2depletion inU-2-OS cells leads to genomic
instability characterized by the appearance of aneuploid cells,
ICBs, and an accumulation of cells in the late S/G2 phase of the
cell cycle (1). Here we further report that hDna2 depletion
results in an increase in-H2AX, awell characterizedmarker of
DNA damage including DSBs, and the appearance of micronu-
clei indicative of aberrant mitosis. U-2-OS cells were trans-
ducedwith one of two shRNAhairpins that led to a greater than
70% reduction in hDna2mRNAand protein levels (Fig. 1,A and
B). Analysis of hDna2-depleted cells revealed a 2-fold increase
in micronuclei compared with cells expressing a control
shRNA (Fig. 1C). Furthermore, hDna2-depleted cells displayed
an increase in -H2AX foci that was confirmed byWestern blot
analysis (Fig. 1, B and D). In addition to the appearance of
-H2AX foci, we also observed phosphorylated-ATM foci in
hDna2-depleted cells (Fig. 1D), confirming that hDna2 deple-
tion results in the generation of DNAdamagewith activation of
the DNA damage checkpoint.
ICBs arise from unresolved replication intermediates, defec-
tive mitosis, and/or telomere fusions that form upon loss of
telomeric integrity (44). Because Dna2 plays an important role
in telomere stability in yeast, we investigated whether the ICBs
observed upon hDna2 depletion were the result of telomeric
fusions. To address this possibility, we analyzed metaphases
from control or hDna2-depleted cells. No increase in chromo-
somal end-to-end fusions was observed in cells expressing
shRNAs targeting hDna2, suggesting that telomere dysfunction
is not responsible for the formation of ICBs in these cells (sup-
plemental Fig. 1). Interestingly, analysis of metaphases isolated
from hDna2-depleted cells revealed the appearance of abnor-
mal chromosomes (Fig. 1E). Thesemetaphases are reminiscent
of chromosomes isolated from cells entering mitosis with
incompletely replicated DNA (45) that could lead to the gener-
ation of ICBs, DSBs, and micronuclei similar to what is
observed in hDna2-depleted cells. Together these experiments
suggest that the genomic instability observed in hDna2-de-
pleted cells arises from incomplete DNA replication.
hDna2 Nuclease andHelicase Activities Are Essential—Dna2
is a highly conserved enzyme that possesses nuclease and heli-
case/ATPase activities that are postulated to contribute to its
function in vivo. Although both activities are essential for via-
bility in S. cerevisiae (46), recent in vitro biochemical studies
have called into question the significance of the helicase activity
in the human protein (5, 6). Therefore, we addressed whether
hDna2 nuclease and/or helicase activities contribute to
genomic stability in mammalian cells. To assess the roles of
these activities, we carried out a series of genetic knockdown-
rescue experiments utilizing an shRNA targeting the 3-un-
translated region (UTR) of endogenous hDna2 while express-
ing a FLAG-tagged shRNA-resistant hDna2 cDNA. We
expressed either a control vector (ctrl) or wild-type (wt) hDna2,
nuclease-deficient D294A (nuc) hDna2, or helicase/ATPase-
deficient K671E (hel) hDna2 cDNA (5). To distinguish between
the endogenous and exogenous hDna2 mRNAs, we designed
specific PCR primers that amplify a region encompassing the
last exon (exon 21) and the 3-UTR of the endogenous hDna2
gene that is absent in the cDNA constructs. This allowed us to
FIGURE 1. hDna2 contributes to genomic maintenance. A, knockdown of
hDna2 inU-2-OS cellswasdeterminedbyquantitative RT-PCR. Results for two
independent hairpins targeting hDna2 (shDna2 and hDna2) are normalized
to the shSCR control cell line expression levels. Note: shDna2 induces a better
knockdown of hDna2 mRNA than shDna2. B, hDna2 knockdown was deter-
mined by Western blot analysis. Lysates were also probed for -H2AX to
assess DNA damage and DSBs. C, shown are relative micronuclei counts and
representative images depictingmicronuclei (red arrows) after hDna2 deple-
tion in cells. Resultswerenormalized to shSCRcontrol cells.D, shown is immu-
nofluorescence staining of -H2AX (red) and phosphorylated-ATM (P-ATM)
(green) inU-2-OS cells depleted of hDna2 (shDna2, bottompanels) or a control
hairpin (shSCR, top panels). Nuclei were stainedwith DAPI (blue). E, left, shown
ismetaphase spread of control cells and hDna2-depleted cellswith abnormal
chromosomes. Right, quantification of 200 metaphases from 2 independent
experiments is shown. All error bars represent S.E., and * denotes p  0.01
compared with shSCR.
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confirm the knockdown of endogenous hDna2 while verifying
ectopic expression of the cDNAs byWestern blot using a FLAG
antibody (Fig. 2, A and B).
We previously demonstrated that depletion of endogenous
hDna2 results in a reduced G1 population, a late S/G2 cell cycle
arrest, and the appearance of aneuploid cells (1). To assess the
role of the helicase and nuclease activity of hDna2, we utilized
flow cytometry tomeasureDNAcontent and determine the cell
cycle profile of cells expressing wild-type or mutant hDna2.
Expression of the wild-type allele significantly rescued the cell
cycle defects observed upon depletion of hDna2 (Fig. 2C). In
contrast, expression of the nuclease-deficient or helicase-defi-
cient alleles did not rescue the cell cycle defects, indicating that
both activities are essential to maintain genomic stability (Fig.
2C). Furthermore, cells expressing the nuclease-deficient
hDna2 protein at even lower levels than the wild-type or heli-
case-deficient mutants displayed cell cycle defects that were
more severe than those observed in cells depleted of endoge-
nous hDna2 alone (Fig. 2, B and C, compare G1/(S G2) ratio,
and cells with4N DNA content). Interestingly, cells express-
ing high levels of the nuclease deficient allele were selected
against over the course of the experiment as evidenced by a
significant reduction in protein level, suggesting that the
nuclease-deficientmutant is either toxic or functions as a dom-
inant negative (Fig. 2, A–C).
To address whether hDna2 helicase activity contributed to
the deleterious properties of the nuclease-deficient Dna2 allele,
we expressed a double mutant (dm) allele lacking both the
hDna2 nuclease and helicase activities. As seen in supplemental
Fig. 2B, expression of the double mutant was maintained at
levels similar to the helicase-deficient protein in contrast to the
nuclease-deficient mutant whose expression was rapidly lost
(supplemental Fig. 2, A and B). These results suggest that the
toxic effect of nuclease-deficient hDna2 depends on its helicase
activity and that both activities are coupled in vivo. Together,
these results demonstrate that the nuclease and helicase activ-
ities of hDna2 are essential to maintain genomic stability.
hDna2 Interacts with Replisome Protein And-1 in a Replica-
tion-dependent Manner—Above, we demonstrate that hDna2
depletion leads to DNA damage and the appearance of meta-
FIGURE 2. hDna2 nuclease and helicase activities contribute to genomic stability. A, shown is a timeline of the experimental procedures given in days;wb
denotes Western blot. B, relative knockdown of hDna2 in U-2-OS cells was determined by quantitative RT-PCR (top panel). Results are normalized to cells
co-expressing the control vector (ctrl) shSCR (). PCR primers used detect only endogenous hDna2 mRNA. cDNA construct expression was confirmed by
anti-FLAG Western blot. C, flow cytometric analysis depicts the cell cycle and DNA content of the U-2-OS cells analyzed in B. bar graphs represent four
independent experiments. Left, shown is the ratio of the percent of cells in G1 versus the percent of cells in SG2. Right, shown is the percent of aneuploid cells
containing abnormally high DNA content (4N). Error bars represent S.E. for four independent experiments, and * denotes p  0.05 compared with cells
co-expressing the control vector shDna2.
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phases reminiscent of cells entering mitosis with incomplete
DNA replication. InXenopus laevis extract, Dna2 is recruited to
DNA shortly after replication licensing where it interacts with
the replisome protein And-1 (47). To determine whether Dna2
associates with the replisome in human cells, we investigated
interactions between hDna2 and And-1.We found that endog-
enous And-1 co-immunoprecipitated with hDna2 from asyn-
chronous cells, suggesting that hDna2 associates with the repli-
some (Fig. 3A and data not shown). Furthermore, comparisons
of the And-1/hDna2 interaction in cells arrested in G0/G1 by
serum starvation and cells blocked at the G1/S border by a dou-
ble thymidine treatment revealed a significant increase in And-
1/hDna2 interaction in cells arrested at theG1/S transition (Fig.
3B). These observations demonstrate that hDna2 specifically
interacts with And-1 in replicating cells and are similar to
observations made in Xenopus extract (47). Together they sug-
gest that hDna2 interacts with And-1 shortly after licensing of
the pre-replication complex as part of the replisome.
hDna2 Depletion Leads to Replication Checkpoint Acti-
vation—Dna2 plays an essential role in DNA replication in
yeast. Our results indicate a corresponding, important role in
human DNA replication. Therefore, we next tested whether
hDna2 depletion altered S phase progression. Control or
hDna2-depleted U-2-OS cells were pulsed with BrdU for 30
min and chased for 12 h. Although hDna2-depleted cells incor-
porated BrdU at the same rate as control cells, they displayed a
marked delay in completing the S/G2 phase and consequently
took longer to appear in the next G1 phase after mitosis (Fig. 4,
A and B) (compare 8-, 10-, and 12-h time points). These obser-
vations support the original cell cycle profiling data and suggest
that hDna2 depletion alters late S/G2 replication rather than
bulkDNAreplication rates during S phase. Furthermore,West-
ern blot analysis revealed a reduction in the phosphorylation of
the mitotic marker histone H3 at serine 10 in depleted versus
control cells, confirming that the block occurs before mitosis
(Fig. 5A, bottom panel).
Complete replication of the genome relies on efficient repli-
cation initiation, progression, and maturation. When replica-
tion is inhibited at any of these steps, cells respond by activating
the S-phase checkpoint. Therefore, given the characteristic
damage and cell cycle arrest observed after hDna2depletion,we
next investigated the activation status of Chk1. Western blot
analysis of hDna2-depleted cells revealed a significant increase
in phosphorylation of Chk1 at serine 317 compared with con-
trol cells, indicative of DNA replication stress (Fig. 5A, top
panel). In agreementwith this finding, we observed an accumu-
lation of single-stranded DNA, a trigger of the S-phase check-
point, as evidenced by a significant increase in the number of
RPA foci per cell in hDna2-depleted cells compared with con-
trol cells (Fig. 5B).
Chk1 activation prevents cells that have not completed DNA
replication frommoving intomitosis (48).WhenChk1 is inhib-
ited in cells undergoing replication stress, they can move into
mitosis with incompletely replicated DNA that if unrepaired
will lead to unresolved replication intermediates. To address
whether checkpoint activation blocked hDna2-depleted cells
from entering mitosis with under-replicated chromosomes
and/or unresolved damage, we treated cells with one of two
Chk1 inhibitors, Gö 6976 or AZD7762 (38, 39). Cells depleted
of hDna2 were grown for 8 h in the presence of the Chk1 inhib-
itor. Flow cytometric analysis revealed a drastic alteration in the
cell cycle profile of hDna2-depleted cells treated with a Chk1
inhibitor compared with untreated cells (Fig. 5C). hDna2-de-
pleted cells treated with the Chk1 inhibitor and released from
the G2 arrest entered mitosis but displayed an increase in ICBs
compared with untreated hDna2-depleted cells, indicating that
cells released from the G2 block underwent aberrant mitosis
(Fig. 5D). Together these experiments establish that cells
depleted of hDna2 display replication defects and arrest in late
S/G2 due to checkpoint activation. Upon checkpoint override,
cells resume cell cycle progression despite incomplete replica-
tion and/or unresolved damage and undergo aberrant mitoses.
Above we demonstrate that hDna2 depletion leads to Chk1
activation and a late S/G2 cell cycle arrest. Chk1 activation after
replicative stress occurs to stabilize ongoing replication forks
FIGURE 3. hDna2 interacts with And-1 in a replication-dependent man-
ner. A, shown is the interaction between hDna2 and And-1 in asynchronous
cells. hDna2 was immunoprecipitated from asynchronous HeLa cells fol-
lowed by Western blot analysis with antibodies against And-1 or hDna2 as
indicated. B, interaction between hDna2 and And-1 occurs during G1/S tran-
sition. HeLa cellswere arrested inG0/G1 by serumstarvationor duringG1/S by
a double thymidine block. hDna2was immunoprecipitated from the arrested
cells, andWestern blot analysiswas performedwith antibodies against And-1
or hDna2 as indicated.
FIGURE 4. hDna2 depletion impedes cell cycle progression in late S/G2. A,
cell cycle progression is shown. U-2-OS cells expressing shSCR or shDna2
were pulsedwith BrdU for 30min and analyzed at the indicated times by flow
cytometry using an anti-BrdU antibody (FITC-conjugated) (y axis) and pro-
pidium iodide toquantifyDNAcontent (x axis). The inset box represents BrdU-
positive cells that are analyzed in B. Red arrows indicate the cells appearing
back in G1 8 and 10 h post-BrdU pulse. B, shown is quantification of BrdU-
positive cells in S/G2 phase (top graph) or BrdU-positive cells appearing in G1
(bottom graph). A representative experiment is shown.
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and to inhibit firing of additional forks (48). Therefore, to exam-
ine the impact of Chk1 activation on origin firing we used
maRTA, wherein DNA is sequentially labeled in vivowith short
pulses of the base analogues IdU and CldU (42). After labeling,
DNA is isolated and stretched on coverslips for detection by
IdU and CIdU immunostaining (Fig. 6A). Using maRTA, we
quantified the fraction of DNA origin firing events present
among all tracks labeled with CldU and IdU. We found that
hDna2-depleted cells displayed a 20–25% reduction in origin
firing events compared with control cells (Fig. 6B). Together,
these experiments establish that hDna2 depletion activates the
replication checkpoint, which in turn inhibits the firing of rep-
lication forks.
Defects in Okazaki Fragment Processing Do Not Alter Repli-
cation Fork Progression—Given the type of DNA damage we
observed after hDna2 depletion and the model established in
yeast suggesting Dna2 participates in OFmaturation (9, 10), we
next examined the role of hDna2 in DNA replication and fork
progression using maRTA. By measuring the lengths of first
label segments within replication tracks containing both labels,
we determined the rate of DNA replication elongation. Using
this method, we found that hDna2 depletion did not alter rep-
lication fork rate. Indeed, we found that DNA track lengths
were similar in control and hDna2-depleted cells (Fig. 7A). This
finding suggests that the damage that arises from unprocessed
DNA fragments accumulating behind the replication fork does
not impede continued replication fork progression and is con-
sistent with our result showing no defects in S phase progres-
sion in hDna2-depleted cells (Fig. 4, A and B).
To further address the possibility that unprocessed OFs do
not impact replication kinetics, we also depleted cells of FEN1
(supplemental Fig. 3) (10). Because FEN1 is themajor OF proc-
essing nuclease in the cell, we expected to find that FEN1 deple-
tion would alter replication fork progression. Strikingly, we
found that FEN1 depletion also failed to slow replication fork
progression. In fact, we found that DNA track lengths were
slightly longer in FEN1-depleted cells compared with control
cells (Fig. 7B and supplemental Fig. 3). Together these obser-
vations strongly suggest that the presence of unprocessed
OFs and the associated damage they generate behind the
replication fork is not sufficient to slow replication fork pro-
gression in vivo.
FIGURE 5. hDna2 depletion activates the replication checkpoint. A, West-
ernblot analysis of control (shSCR) andhDna2-depleted (shDna2) U-2-OS cells
is shown. Whole cell lysates were probed for total versus phosphorylated-
Chk1 (P-Chk1 S317) (top panels). Samples were also probed for phosphorylat-
ed-histoneH3 (P-H3 S10). B, immunofluorescence staining of RPA-70 in shSCR
and shDna2 U-2-OS cells is shown. Cells were pre-extracted before fixing and
staining to eliminate cytoplasmic RPA-70 (37). Quantification of RPA foci:
average number (left) and total number (right) of foci per cell. * denotes p
0.01. C, cell cycle distribution of shSCR and shDna2/ treatmentwith Chk1
inhibitor (Gö 6976) for 8 h. Similar results were obtained when AZD7762 was
used to inhibit Chk1 (data not shown). D, ICBs (1) were quantified in control
(shSCR) and hDna2-depleted (shDna2) U-2-OS cells Chk1 inhibitor. A repre-
sentative image is shown with an ICB indicated by an arrow. * denotes p 
0.01.
FIGURE 6. hDna2 depletion reduces origin firing. A, shSCR or shDna2
U-2-OS cells were labeled consecutively with IdU (green) and CldU (red) for 30
min each before isolating and stretching DNA for immunostaining. B, origin
firing events among all tracks labeled were identified as CldU-only (red only)
or CldU-IdU-CldU (red-green-red) triple-segment tracks. The mean percent-
ages of new origin firing events defined by these two track types among all
labeled tracks are shown for three independent experiments in which 200–
450 tracks/experiment were analyzed for control shSCR or shDna2. Error bars
show S.E. between three independent experiments. * denotes p 0.05.
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hDna2DepletionDoesNot Lead toDetectableDefects inMat-
uration of Newly Synthesized DNA—Long flaps requiring Dna2
for processing are predicted to arise in only a small percentage
of OFs, and in specific regions of the genome (4, 12, 20). There-
fore, the need forDna2 should be dispensable for processing the
vast majority of OFs, in contrast to the short flaps that are
cleaved by FEN1. To determine whether hDna2 participates in
OF processing, we measured the maturation kinetics of newly
replicated DNA using a BrdU-comet assay.We reasoned that if
hDna2 were necessary to process only a minority of the flaps, it
would be difficult to observe maturation differences in cells
depleted of hDna2 alone. Therefore, we also depleted FEN1 in
addition to hDna2 in an effort to increase the accumulation of
long flaps that would require Dna2 activity. In parallel, we also
depleted cells of DNA ligase I (LigI) as a positive control; LigI is
required to ligate OF, which is required to complete OF proc-
essing (41). Western blot analysis demonstrated that we suc-
cessfully depleted FEN1, LigI, or hDna2 alone and co-depleted
FEN1 and hDna2 (Fig. 8A).
To assess the maturation of newly replicated DNA, control
cells and cells depleted of hDna2, FEN1, or LigI alone or co-de-
pleted of both hDna2 and FEN1 were pulsed with BrdU and
analyzed by an alkaline comet assay. Immunofluorescence
against BrdUwas used to assess the integrity of newly replicated
DNA by measuring its migration from the tail (unligated DNA
fragments, i.e. unprocessed OFs) to the head (ligated DNA, i.e.
processed OFs) of the comet (Fig. 8B compare 1-h to 8-h
images). As expected, LigI depletion slowed the maturation of
newly replicated DNA from comet tails to heads (Fig. 8C) (41).
In contrast, we failed to observe a significant difference in OF
maturation in hDna2-depleted compared with control cells
(Fig. 8C). Furthermore, FEN1-depleted cells displayed a reduc-
tion similar to that of LigI-depleted cells, indicating that FEN1
is the major flap endonuclease responsible for processing OFs
during lagging strand replication. Finally, OF maturation did
not differ in FEN1-hDna2 co-depleted cells comparedwith cells
depleted of FEN1 alone (Fig. 8C), suggesting that hDna2 does
not compensate for FEN1 loss in OF processing. These results
indicate that the DNA damage that arises upon hDna2 deple-
tion (Fig. 9C, compare shDna2 to shFEN1 -H2AX levels) is
unlikely to arise from a global OF maturation defect. However,
it does not rule out a role for hDna2 in thematuration of a small
fraction of OFs.
To further assess whether hDna2 primary function in DNA
replication involves OF processing, we ectopically expressed
FEN1 in hDna2-depleted cells (Ref. 33 and data not shown). In
yeast, FEN1 overexpression compensates for phenotypes
caused by hypomorphic mutations of Dna2 (8). However,
ectopic expression of FEN1 in human cells did not improve the
cell cycle defects observed in hDna2-depleted cells (Fig. 9, A
and B). These results further reinforce the contention that the
key role of hDna2 in DNA replication is independent of FEN1
or OF processing.
DISCUSSION
In this study we provide evidence that hDna2 is essential to
ensure faithful replication of the genome like its yeast homo-
logue and that unlike in yeast this essential role is independent
of a requirement for hDna2 in globalOFprocessing.We further
demonstrate that both the nuclease and helicase activities of
hDna2 contribute to genomic stability in human cells as they do
in yeast. Finally, we report the unexpected finding that defective
OF processing has no detectable impact on replication fork
progression. This surprising result indicates that fork move-
ment is decoupled from damage that arises behind the replica-
tion fork.
In S. cerevisiae, temperature-sensitive dna2 mutant alleles
arrest cells in G2 with a 2C DNA content when shifted to the
restrictive temperature (49). In Schizosaccharomyces pombe,
temperature-sensitive mutants also arrest in late S phase but
display no defects in bulk DNA synthesis (4). When combined
with a checkpoint inhibitor, these cells bypass the arrest and
undergo aberrant mitosis. Similarly, here we demonstrate that
hDna2-depleted cells harbor DNA damage and arrest in late
FIGURE7.Replication forkprogression isunperturbed inhDna2-orFEN1-
depleted cells.A, quantificationof three independentmaRTAexperiments is
shown on the right. The bar graph summarizes mean lengths of first-label
segments labeled for 30 min in two-segment tracks (i.e. tracks labeled con-
secutively with IdU and CIdU) to ensure that fork rate measurements were
made from active replication forks. Error bars show 95% confidence intervals
for sample means. No statistical difference in mean track lengths was
observed between shSCR and shDna2 cells using a two-sample Kolmogorov-
Smirnov test. B, shown are quantification of three independent experiments
summarizing mean track length of the first label in cells depleted of FEN1
(shFEN1, shFEN1) or control cells (shSCR).
HumanDna2 Participates in DNA Replication
JUNE 22, 2012•VOLUME 287•NUMBER 26 JOURNAL OF BIOLOGICAL CHEMISTRY 21987
S/G2 phase. Upon Chk1 inhibition, cells bypass the replication
checkpoint and progress through mitosis, displaying aberrant
mitotic structures (increase in ICBs; Fig. 5D). These pheno-
types recapitulate observations in yeast and strongly suggest a
conserved role for Dna2 in DNA replication in humans. Sup-
porting our conclusions, ectopic expression of hDna2 sup-
presses the growth defects of the replication mutant dna2–1 in
S. cerevisiae (50).
The requirement for Dna2 helicase activity for yeast viability
in S. cerevisiae indicates that this function is required in vivo
(46). Indeed, different studies have demonstrated that Dna2
helicase activity is essential for efficient cleavage of long DNA
flaps that may form secondary structures (7, 51). However, sev-
eral studies demonstrated that the helicase activity of hDna2 is
weak or undetectable andmight not serve a corresponding role
in human cells (5, 6). Our observation that neither nuclease nor
helicase-deficient hDna2 mutants rescue hDna2 depletion
demonstrates that both activities are essential to ensure the
integrity of the genome. Furthermore, we provide evidence that
as in yeast, hDna2 nuclease-deficient expression is toxic to the
cell (46, 51). This toxicity depends on its helicase activity, sug-
gesting that both activities need to be coupled within a single
Dna2molecule to act on its substrates in vivo. This is in contrast
to Dna2 function in 5 end resection during DSB repair where
only the nuclease activity of Dna2 participates in this process
(24, 28, 29, 53).
OF processing is an essential process that ensures a continu-
ous lagging DNA strand and avoids single and double strand
break formation. Several prior studies have suggested that
defects in OF processing do not impact the rate of DNA syn-
FIGURE 8. hDna2 depletion does not impact Okazaki fragment maturation. BrdU-comet analysis of U-2-OS cells depleted of FEN1 (shFEN1), hDna2
(shDna2), LigI (shLigI), or co-depleted of FEN1 and hDna2 (shFEN1 shDna2). Cells were pulsed for 15 min with BrdU and chased for 1 or 8 h before comet
processing. A, shown isWestern blot analysis of the different cell lines probed for LigI, FEN1, and hDna2. B, representative images of the different samples at 1
and8hpost-BrdUpulse are shown. Cellswere immunostained for BrdU (green), andDNAwas stainedwithDAPI (blue).C, shown is quantification of thepercent
BrdU-positive DNA in the tail versus the comet head at the 8-h time point. Results are based on the analysis of 40–65 comets per experiment. A total of three
independent experiments were performed, and the errors bars correspond to the S.E. The total number of cells analyzed per sample is shown in parenthesis. *
denotes p 0.05 comparing shFEN1, shFEN1shDna2, or shLigI to shSCR.
FIGURE 9. FEN1 overexpression does not compensate for hDna2 deple-
tion. A, hDna2-depleted (shDna2) or control U-2-OS cells (shSCR) were trans-
duced with either GFP (ctrl) or FLAG-FEN1 (FEN1). Immunofluorescence
images against FLAG demonstrated70% of transduction of FEN1 express-
ing cells (data not shown). Flow cytometry histograms of the cell cycle distri-
butionof the respective cell lines aredepictedwith the cell count represented
on the yaxis andDNAcontenton the xaxis.B, quantificationof two independ-
ent experiments is shown. Left, shown is a graph representing the ratio of the
percent of cells in G1 versus the percent of cells in SG2. Right, shown is a
graph representing thepercent of cells containingabnormally highDNAcon-
tent (4N). Error bars represent S.E. C. -H2AX levels were determined by
Western blot analysis in FEN1- or hDna2-depleted cells.
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thesis. Indeed, we previously demonstrated that FEN1 deple-
tion did not slow S-phase progression or SV40 LargeT antigen-
dependent DNA replication in vitro (33). Similarly, LigImutant
cells (46BR.1G1) that exhibit low LigI activity do not activate
the intra-S phase checkpoint (41). Although protein extracts
from these cells are deficient in OF ligation during SV40 DNA
replication in vitro, they support incorporation of [-32P] dATP
into plasmidDNAwith similar kinetics as extracts from control
fibroblasts (56). In addition, yeast deficient in LigI completely
replicate their genomes despite being unable to ligate OF (54,
55). Together these studies suggest that replication fork pro-
gression is unperturbed in the absence of LigI. Here, using the
sensitive maRTA technique, we demonstrate that depletion of
an essential OF maturation protein, FEN1, does not alter repli-
cation fork progression in vivo. These observations strongly
suggest that flaps that persist behind the replication fork do not
affect the synthesis rate of DNA during replication.
FEN1 is postulated to be the primary endonuclease that pro-
cesses flaps produced during lagging strand synthesis. How-
ever, both genetic and biochemical data indicate the presence
of an additional long-flap processing pathway. Long DNA flap
formation is promoted by PIF1 in vitro and requiresDna2 activ-
ity to create shorter flaps that are cleaved by FEN1 to generate a
ligatable nick (9, 10, 14). To address the role of hDna2 in long-
flap processing in human cells, we depleted FEN1 and hDna2
independently or together and then measured the maturation
of nascent DNA.We found that maturation occurs with slower
kinetics in FEN1-depleted cells, thus confirming FEN1 as the
primary endonuclease responsible for processing OFs in
human cells. In contrast, we did not observe a defect in matu-
ration in hDna2-depleted cells. This indicates that if hDna2
processes long flaps, it does not represent a significant fraction
ofOFs in accordancewith themodel. However, our finding that
FEN1-hDna2 co-depletion did not result in a significant differ-
ence in OF maturation rate compared with cells depleted of
FEN1 alone was surprising, as in yeast dna2 and rad27, muta-
tions are synergistic (8). These results suggest either long flaps
do not form readily in the absence of FEN1 in human cells or
that another nuclease can process flaps to render them ligat-
able. In yeast, other nucleases such as RNaseH2 or Exo1 can
compensate for FEN1 loss by processing short flaps (20, 57–59).
It remains to be seen whether their functions are conserved in
humans. Despite the apparent functional dominance of FEN1,
we were surprised to find that hDna2-depleted cells display
more DNA damage than FEN1-depleted cells as assessed by
-H2AX levels and abnormal cell cycle profile (Fig. 9B and data
not shown). One explanation for this is that even infrequent
unprocessed long flaps are a source ofDNAdamage and genetic
instability in the absence of hDna2. However, we find this to be
unlikely because ectopic FEN1 expression had no impact on the
defects observed in hDna2-depleted cells. Thus a more likely
and interesting possibility is that hDna2 has an important, as
yet to be elucidated, role in replication or DNA repair beyond
its postulated role inOFprocessing. This possibility is strength-
ened by our observation that hDna2 interacts with And-1 spe-
cifically in replicating but not resting human cells. This inter-
action is in accordance with yeast and Xenopus observations
(47, 52, 60, 61) and suggests that hDna2 is a component of the
replication fork. The late S/G2 phase arrest and appearance of
aberrant post-mitotic structures could suggest a role for hDna2
in completing DNA replication by aiding in the resolution of
replication intermediates. Interestingly, the Bloom RecQ heli-
case can resolve late replication intermediates, and its ectopic
expression rescues Dna2 mutants in yeast (50). Alternatively,
XenopusDna2has beenproposed to play a role in the early steps
of DNA replication (3, 47). It remains to be addressed whether
hDna2 actively participates in any of these processes.
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